ADMA Biologics, Inc. (ADMA)

ADMA Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,643	1,021	763	276	184	237
Market Cap Growth	104.84%	33.78%	176.53%	49.75%	-22.30%	114.19%
Enterprise Value	2,729	1,102	821	320	222	294
PE Ratio	-	-36.17	-11.58	-3.85	-2.43	-4.91
PS Ratio	9.33	3.96	4.96	3.41	4.37	8.09
PB Ratio	17.19	7.55	5.02	1.96	2.09	9.06
P/FCF Ratio	163.82	253.51	-10.40	-2.19	-1.61	-2.97
P/OCF Ratio	124.04	116.07	-12.83	-2.46	-1.81	-3.11
EV/Sales Ratio	9.64	4.27	5.33	3.96	5.25	10.02
EV/EBITDA Ratio	97.32	215.17	-20.77	-6.04	-3.71	-8.16
EV/EBIT Ratio	139.02	-342.98	-17.60	-5.47	-3.48	-7.48
EV/FCF Ratio	169.19	273.43	-11.18	-2.55	-1.93	-3.67
Debt / Equity Ratio	0.86	0.97	0.95	0.68	1.06	3.19
Debt / EBITDA Ratio	4.70	25.71	-3.64	-1.80	-1.56	-2.32
Debt / FCF Ratio	8.18	32.67	-1.96	-0.76	-0.81	-1.04
Quick Ratio	1.79	1.58	2.60	2.62	3.47	2.15
Current Ratio	5.21	5.16	6.89	6.87	7.71	6.12
Asset Turnover	0.83	0.76	0.49	0.33	0.21	0.24
Interest Coverage	0.87	-0.13	-2.42	-4.49	-5.32	-4.37
Return on Equity (ROE)	-2.50%	-19.50%	-53.40%	-61.20%	-91.00%	-161.90%
Return on Assets (ROA)	-1.10%	-8.30%	-21.00%	-29.10%	-37.90%	-39.70%
Return on Capital (ROIC)	15.50%	8.11%	-13.31%	-24.67%	-35.75%	-37.79%
Earnings Yield	-0.14%	-2.76%	-8.63%	-25.95%	-41.09%	-20.35%
FCF Yield	0.61%	0.39%	-9.62%	-45.59%	-62.23%	-33.72%
Buyback Yield / Dilution	-6.53%	-13.19%	-41.77%	-62.03%	-58.51%	-20.27%
Total Shareholder Return	-6.53%	-13.19%	-41.77%	-62.03%	-58.51%	-20.27%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).